Testing times: how medtech firms can get the most from the annual business review
This article was originally published in Clinica
Executive Summary
Most medtech companies find the annual business plan review an unsatisfactory process. Research into those few who do find the process beneficial reveal three valuable lessons, writes Prof Brian Smith